Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-08-19
Oligo (dT) 25 Beads support selective capture and purification of polyadenylated eukaryotic mRNA from total RNA or animal and plant samples. They are appropriate for polyA-selected RNA workflows, but they should not be treated as a general total RNA cleanup method or as a validated solution for non-polyadenylated transcripts.
BV6 IAP Antagonist: Mechanism and Research Use
2026-08-19
BV6 is a Smac mimetic and IAP antagonist used to study apoptosis induction in cancer cells, radiosensitization of non-small cell lung cancer, and endometriosis treatment research. Product information reports an IC50 of 7.2 μM in H460 cells and describes activity in cellular, immune-cell, and mouse disease models.
From Exosomal Wnt10a to Reproducible Fluorescence
2026-08-18
Translational osteogenesis research depends on more than a compelling mechanism: it requires readouts that preserve spatial, cellular, and pathway-level evidence. This thought-leadership article connects lithium-engineered exosomal Wnt10a biology with practical assay strategy using the Cy5 Goat Anti-Mouse IgG (H+L) Antibody for reproducible fluorescence workflows.
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-08-18
Wang et al. identify METTL16 as a ferroptosis-repressing regulator that promotes hepatocellular carcinoma through an m6A-dependent METTL16–SENP3–LTF pathway. The study connects RNA modification, protein de-SUMOylation, and iron sequestration, offering a mechanistic rationale for sensitizing HCC to ferroptosis-based treatment.
HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody
2026-08-17
Build sensitive immunofluorescence, Western blot, flow cytometry, IHC, and ELISA workflows around a single affinity-purified fluorescent secondary. The key differentiator is broad human IgG heavy- and light-chain recognition, paired with practical guidance for separating true assay sensitivity from species mismatch, background, and photobleaching.
Apicidin: Epigenetic Leverage, Translational Caution
2026-08-16
Apicidin is more than a laboratory histone deacetylase inhibitor: it is a mechanistic probe that connects HDAC biology, cancer research, angiogenesis, and reproductive toxicology. This thought-leadership article translates recent oocyte findings into practical guidance for experimental design, target validation, and translational risk assessment.
HyperScribe SP6 High Yield RNA Synthesis Kit
2026-08-15
The HyperScribe SP6 High Yield RNA Synthesis Kit is an SP6 RNA polymerase kit for modification-compatible in vitro transcription. Its stated benchmark is at least 50 μg of RNA from a standard 20 μL reaction containing 1 μg of control template.
DHT and Microenvironmental Resistance Research
2026-08-14
Dihydrotestosterone is more than an androgen receptor agonist: it is a precise perturbation tool for studying receptor crosstalk, EGFR–ERBB2 signaling, and microenvironment-driven resistance in translational cancer research.
Rucaparib (AG-014699): PARP1 Research Guide
2026-08-14
Rucaparib, also called AG-014699 or PF-01367338, is a potent PARP1 inhibitor for DNA damage response research. Its reported activity, formulation properties, transporter biology, and radiosensitization context support controlled cancer biology research workflows rather than direct clinical inference.
DiscoveryProbe Bioactive Compound Library Plus Workflow
2026-08-13
Use the DiscoveryProbe Bioactive Compound Library Plus to connect thermal-shift ligand discovery with pathway-aware validation. Its broad, pre-dissolved collection supports bacterial sensor studies, protease inhibitor screening, and carefully staged follow-up in apoptosis, cancer research, and signaling assays.
Plerixafor (AMD3100) in Tumor Trafficking Assays
2026-08-13
Plerixafor (AMD3100) is more than a CXCR4 antagonist: it is a mechanistic probe for CXCL12-directed cell trafficking. This article explains how to apply it to platelet extravasation, cancer metastasis inhibition, stem-cell mobilization, and assay design.
Direct Mouse Genotyping Kit for Assay Reliability
2026-08-12
Learn how Direct Mouse Genotyping Kit K1025 can reduce DNA-preparation steps when assigning mouse genotypes before viability, proliferation, or cytotoxicity studies. This scenario-based guide covers compatibility, protocol controls, interpretation, storage, and practical vendor-selection criteria.
Ultrathin OA/F-Fc Nanosheets for Tumor Therapy
2026-08-12
A 2026 ACS Nano study reports a premix-dropwise-stir strategy for producing ultrathin oleanolic acid/perfluorocarbon-ferrocene nanosheets without a separate carrier. The resulting system combines oxygen self-supply, ferrocene-mediated chemodynamic therapy, reactive oxygen and nitrogen species generation, antifibrotic activity, macrophage modulation, and tumor penetration to remodel the tumor microenvironment.
FLNa, NF-κB, and HEV Replication
2026-08-11
The reference study identifies filamin A (FLNa) as a host cytoskeletal factor that links HEV infection to NF-κB signaling, apoptosis, and inflammatory responses. Its cross-system design suggests that loss of FLNa helps HEV evade innate sensing and promotes viral replication and release, while also highlighting a testable host-pathway framework for future antiviral research.
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-08-10
Phosphatase Inhibitor Cocktail (2 Tubes, 100X) helps limit endogenous phosphatase activity during sample preparation so phosphorylation-dependent signals are less likely to change before analysis. It is intended for research workflows such as immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry, but it is not a diagnostic or medical reagent and requires application-specific compatibility testing.
458 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page